Soligenix (SNGX) Competitors $1.24 -0.03 (-1.98%) As of 10:39 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNGX vs. QTTB, LPCN, CING, MTEX, GELS, CARM, MRKR, CTXR, RVPH, and PMNShould you be buying Soligenix stock or one of its competitors? The main competitors of Soligenix include Q32 Bio (QTTB), Lipocine (LPCN), Cingulate (CING), Mannatech (MTEX), Gelteq (GELS), Carisma Therapeutics (CARM), Marker Therapeutics (MRKR), Citius Pharmaceuticals (CTXR), Reviva Pharmaceuticals (RVPH), and Promis Neurosciences (PMN). These companies are all part of the "pharmaceutical products" industry. Soligenix vs. Its Competitors Q32 Bio Lipocine Cingulate Mannatech Gelteq Carisma Therapeutics Marker Therapeutics Citius Pharmaceuticals Reviva Pharmaceuticals Promis Neurosciences Q32 Bio (NASDAQ:QTTB) and Soligenix (NASDAQ:SNGX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations. Do insiders & institutionals have more ownership in QTTB or SNGX? 31.3% of Q32 Bio shares are owned by institutional investors. Comparatively, 3.6% of Soligenix shares are owned by institutional investors. 40.0% of Q32 Bio shares are owned by company insiders. Comparatively, 3.1% of Soligenix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is QTTB or SNGX more profitable? Soligenix's return on equity of -223.89% beat Q32 Bio's return on equity.Company Net Margins Return on Equity Return on Assets Q32 BioN/A -447.33% -59.77% Soligenix N/A -223.89%-103.50% Which has higher earnings and valuation, QTTB or SNGX? Soligenix has lower revenue, but higher earnings than Q32 Bio. Q32 Bio is trading at a lower price-to-earnings ratio than Soligenix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQ32 Bio$1.16M14.99-$47.73M-$4.94-0.29Soligenix$120K33.55-$8.27M-$4.29-0.29 Do analysts rate QTTB or SNGX? Q32 Bio presently has a consensus target price of $12.17, indicating a potential upside of 753.80%. Given Q32 Bio's stronger consensus rating and higher probable upside, analysts plainly believe Q32 Bio is more favorable than Soligenix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Q32 Bio 0 Sell rating(s) 6 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25Soligenix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility & risk, QTTB or SNGX? Q32 Bio has a beta of -0.07, indicating that its stock price is 107% less volatile than the S&P 500. Comparatively, Soligenix has a beta of 1.87, indicating that its stock price is 87% more volatile than the S&P 500. Does the media favor QTTB or SNGX? In the previous week, Q32 Bio had 1 more articles in the media than Soligenix. MarketBeat recorded 2 mentions for Q32 Bio and 1 mentions for Soligenix. Soligenix's average media sentiment score of 0.93 beat Q32 Bio's score of 0.47 indicating that Soligenix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Q32 Bio 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Soligenix 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryQ32 Bio beats Soligenix on 8 of the 15 factors compared between the two stocks. Get Soligenix News Delivered to You Automatically Sign up to receive the latest news and ratings for SNGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNGX vs. The Competition Export to ExcelMetricSoligenixMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.01M$2.90B$5.50B$9.00BDividend YieldN/A2.64%5.39%4.10%P/E Ratio-0.2921.2326.5720.02Price / Sales33.55280.33415.46120.95Price / CashN/A41.4736.1356.90Price / Book0.757.498.065.50Net Income-$8.27M-$55.05M$3.15B$248.50M7 Day Performance-9.85%2.58%1.72%2.61%1 Month Performance-36.67%5.22%3.92%5.42%1 Year Performance-44.62%5.04%35.02%20.76% Soligenix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNGXSoligenix1.3745 of 5 stars$1.24-2.0%N/A-44.5%$4.01M$120K-0.2920Gap DownQTTBQ32 Bio2.7628 of 5 stars$1.49+2.8%$12.17+716.6%-92.0%$17.69M$1.16M-0.3039LPCNLipocine2.0592 of 5 stars$3.16-4.0%$9.00+184.8%-58.9%$17.60M$11.20M-3.1010CINGCingulate3.0163 of 5 stars$4.07+0.5%$26.00+538.8%+1,264.8%$17.19MN/A-0.4820Positive NewsMTEXMannatech0.6034 of 5 stars$9.35+3.9%N/A+30.1%$17.11M$117.87M-93.50250High Trading VolumeGELSGelteqN/A$1.73-4.4%N/AN/A$17.08M$100K0.00N/ACARMCarisma Therapeutics2.4368 of 5 stars$0.39-2.2%$1.93+391.6%-70.8%$16.74M$19.63M-0.2520News CoverageGap DownMRKRMarker Therapeutics4.2796 of 5 stars$1.53+4.8%$13.17+760.6%-70.0%$16.52M$6.59M-1.1560Positive NewsCTXRCitius Pharmaceuticals2.6982 of 5 stars$1.59+3.9%$53.00+3,233.3%-83.6%$16.27MN/A0.0020Analyst ForecastGap UpHigh Trading VolumeRVPHReviva Pharmaceuticals2.6231 of 5 stars$0.38+12.9%$9.00+2,261.6%-64.4%$16.20MN/A-0.485High Trading VolumePMNPromis Neurosciences3.6501 of 5 stars$0.48+0.7%$4.50+830.1%-73.0%$15.70MN/A-9.685Positive News Related Companies and Tools Related Companies Q32 Bio Competitors Lipocine Competitors Cingulate Competitors Mannatech Competitors Gelteq Competitors Carisma Therapeutics Competitors Marker Therapeutics Competitors Citius Pharmaceuticals Competitors Reviva Pharmaceuticals Competitors Promis Neurosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNGX) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soligenix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soligenix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNGX Stock Alerts